We found that, as a consequence of the EGFR inhibition, CL4 strongly inhibits the anti-apoptotic STAT3 and induces cell death selectively in EGFR-positive cancer cells by activation of caspase-3, caspase-8 and PARP. Here, STAT3 is linked to cancer.